BIVI
BIOVIE-A (BIVI)
NASDAQ
$1.96+$0.007 (+0.36%)
Price as of Aug 21, 2026 7:59 PM EDT
  • $14.7M
    Market Cap
  • 21.88%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2026
06/30/2025
06/30/2024
06/30/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
8.6M
-3.16%
8.8M
-23.39%
11.6M
+18.29%
Research and Development Expense
-14.0M
+50.67%
-9.3M
-59.88%
-23.1M
-30.63%
-33.3M
+92.95%
Depreciation and Amortization Expense
178,341
-22.25%
229,377
0.00%
229,377
0.00%
229,377
0.00%
Total Operating Expenses
22.7M
+25.38%
18.1M
-43.86%
32.2M
-28.62%
45.1M
+65.41%
Operating Profit
-22.7M
+25.38%
-18.1M
-43.86%
-32.2M
-28.62%
-45.1M
+65.41%
Interest Income
596,771
-30.04%
853,029
-24.96%
1.1M
+102.17%
562,264
+1,175.55%
Interest Expense
-17,901
-94.26%
-312,000
-89.22%
-2.9M
-32.70%
-4.3M
+98.81%
Interest Income and Expense and Net
578,870
+6.99%
541,029
+130.79%
-1.8M
-52.99%
-3.7M
+76.41%
Total Nonoperating Income and Expense
578,870
+10.45%
524,080
+787.49%
59,052
-98.63%
4.3M
+98.81%
Income before Taxes
-22.1M
+23.48%
-17.9M
-45.73%
-33.0M
-34.32%
-50.3M
+92.67%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-22.1M
+25.83%
-17.5M
-45.39%
-32.1M
-36.09%
-50.3M
+92.67%
Net Income from Continuing Operations Applicable to Common
-22.1M
+25.83%
-17.5M
-46.85%
-33.0M
-34.32%
-50.3M
+92.67%
Basic EPS and Net Income
-3.05
-74.83%
-12.12
+66.03%
-7.30
+370.97%
-1.55
+46.23%
Diluted EPS and Net Income
-3.05
-74.83%
-12.12
+66.03%
-7.30
+370.97%
-1.55
+46.23%
Basic Weighted Average Shares
7.2M
+390.46%
1.5M
-67.30%
4.5M
-86.09%
32.5M
+31.71%
Diluted Weighted Average Shares
7.2M
+390.46%
1.5M
-67.30%
4.5M
-86.09%
32.5M
+31.71%
Balance Sheet
Cash and Cash Equivalents
9.0M
-48.83%
17.5M
-26.42%
23.8M
+22.52%
19.5M
+4.39%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
9.0M
-48.83%
17.5M
-26.42%
23.8M
+22.52%
19.5M
+4.39%
Total Current Assets
13.6M
-34.09%
20.7M
-13.93%
24.0M
-29.36%
34.0M
+81.27%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
14.3M
-33.91%
21.6M
-14.46%
25.2M
-28.19%
35.1M
+74.52%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
5.7M
-37.38%
9.1M
N/A
Total Current Liabilities
3.8M
+66.86%
2.3M
-75.68%
9.4M
-35.48%
14.5M
+247.66%
Total Long-Term Debt
N/A
N/A
N/A
N/A
5.0M
-4.35%
5.2M
-56.94%
Total Long-Term Liabilities
184,421
-33.04%
275,430
-21.28%
349,894
-93.36%
5.3M
+10,791.34%
Total Liabilities
4.0M
+56.07%
2.6M
-73.71%
9.7M
-50.91%
19.8M
+20.19%
Retained Earnings
-374.3M
+6.28%
-352.1M
+5.36%
-334.2M
+10.96%
-301.2M
+20.02%
Total Stockholders Equity
10.3M
N/A
N/A
N/A
15.5M
+1.08%
15.3M
+317.88%
Total Shares Outstanding
7.5M
+294.03%
1.9M
-69.08%
6.2M
-83.01%
36.4M
+45.81%
Cash Flow
Cash from Operating Activities
-19.0M
-0.002%
-19.0M
-31.92%
-27.9M
-30.58%
-40.3M
+111.96%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
14.5M
+201.57%
-14.3M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.5M
-17.82%
12.7M
-28.52%
17.8M
-67.85%
55.4M
+67.18%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-123.27%
+64.33%
-75.01%
-29.57%
-106.51%
-41.48%
-182.02%
-8.72%
Return on Equity
N/A
N/A
N/A
N/A
-208.26%
-60.61%
-528.70%
-11.62%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.59
-60.50%
9.10
+253.86%
2.57
+9.49%
2.35
-47.86%
Cash Ratio
2.37
-69.33%
7.71
+202.51%
2.55
+89.89%
1.34
-69.97%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
0.69
-26.14%
0.93
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
0.42
+3.97%
0.41
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow